Serum alpha‐fetoprotein and variant alkaline phosphatase in human hepatocellular carcinoma | Zendy

Poertugal M. L. | Zendy; Azevedo M. S. | Zendy; Manso Carlos | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

Serum alpha‐fetoprotein and variant alkaline phosphatase in human hepatocellular carcinoma

Author(s) -

Poertugal M. L.,

Azevedo M. S.,

Manso Carlos

Publication year - 1970

Publication title -

international journal of cancer

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.475

H-Index - 234

eISSN - 1097-0215

pISSN - 0020-7136

DOI - 10.1002/ijc.2910060308

Subject(s) - alkaline phosphatase , alpha fetoprotein , hepatocellular carcinoma , alpha (finance) , incidence (geometry) , medicine , carcinoma , phosphatase , biology , gastroenterology , chemistry , pathology , endocrinology , biochemistry , enzyme , physics , surgery , construct validity , optics , patient satisfaction

Alpha‐fetoprotein and variant alkaline phosphatase were studied in a group of patients with hepatoma. The incidence of positive alpha‐fetoprotein was 67.6% in confirmed cases. Variant alkaline phosphatase was present only in patients with positive fetoprotein test, and it appeared in only 28.6% of the cases.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research